Safety and Biomarker Study of EPI-589 in Participants With Amyotrophic Lateral Sclerosis (ALS)
Clinical trial NCT02460679 · COMPLETED
Trial details
- NCT number
- NCT02460679
- Sponsor
- PTC Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-14
- Primary completion
- 2018-02-23
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.